Supernus Pharmaceuticals' GAAP net income for 2021 was $53.424 million, down 2.4 times from $126.95 million in the previous year. Revenue increased 11.4% to $579.775 million from $520.397 million a year earlier.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept